Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer
Daniel Sentana‐Lledo, Hollis Viray, Andrew J. Piper‐Vallillo, Page Widick, Deepa Rangachari, Jennifer L. Wilson, Sidharta P. Gangadharan, Joseph A. Aronovitz, Stuart M. Berman, Paul A. VanderLaan, Daniel B. Costa
Topics & Concepts
MedicineAlectinibNeoadjuvant therapyLung cancerOncologyAdenocarcinomaRadiation therapyInternal medicineAnaplastic lymphoma kinaseChemotherapyCancerBreast cancerMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers